Recon: Novartis sues over IRA drug pricing negotiation; Novo’s Wegovy launches in UK to pent-up demand

Recon

ReconJason Scott

Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy